New research finds cheaper battery material could help fight off colon cancer in older adults

1 min read

Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A.

Researchers Chen J et al identified mRNA N4-acetylcytidine (ac 4 C) modification as a critical regulator of human colonic epithelial cell senescence. They found that knockdown of NAT10 significantly alleviates human colonic epithelial cell senescence in vitro and colonoid, and intestinal aging in vivo in aged mice. This suggests that NAT10 plays a role in the imbalance between cell senescence and mucosal self-renewal that increases susceptibility to elderly-onset ulcerative colitis.

The researchers used transcriptome sequencing to reveal how NAT10 affects DYRK1A mRNA stability. They found that NAT10 stabilizes DYRK1A mRNA through ac 4 C modification, which drives colon epithelial senescence. Furthermore, NAT10 and DYRK1A are upregulated in ulcerative colitis tissues from elderly patients, and their levels positively correlate with disease severity.

Knockdown of NAT10 or treatment with NAT10 or DYRK1A inhibitor alleviates colitis in aged mice. These findings collectively suggest that modulating NAT10-mediated RNA ac 4 C modification could rejuvenate intestinal aging and provide a novel therapeutic strategy for elderly-onset colitis.

As we contemplate the intricate mechanisms underlying human health, it is humbling to recognize our own mortality and the vulnerabilities that come with age. The discovery of NAT10's role in driving colon epithelial senescence reminds us of the complex interplay between cellular processes and disease progression, a reminder that even the smallest disruptions can have profound effects on our well-being.

1 min read

In the innermost workings of our bodies, a silent struggle is waged between life and death. The lining of our intestines, a delicate balance of cells that should renew themselves with each passing day, begins to falter with age. This decline in cellular renewal can have devastating consequences: an increased susceptibility to ulcerative colitis, a condition that robs the elderly of their quality of life.

Researchers have now identified the culprit behind this imbalance: a molecule called NAT10. Found to regulate the modification of RNA molecules, NAT10 plays a critical role in driving cellular senescence - the premature aging of cells. By targeting NAT10, scientists hope to rejuvenate the intestinal lining and alleviate the symptoms of ulcerative colitis.

The breakthrough comes from a deeper understanding of how NAT10 interacts with another molecule called DYRK1A. The researchers found that NAT10 stabilizes DYRK1A mRNA through a specific modification, leading to an increase in cellular senescence. This discovery opens up new avenues for therapy, offering hope to those suffering from elderly-onset colitis and its debilitating effects on the body's inner workings.

1 min read

In the depths of our bodies, there's a tiny spark that can ignite a fire of health and renewal. Scientists have discovered that by targeting a small protein called NAT10, we can unlock the secrets to rejuvenating an aging gut.

Imagine your intestines as a garden, where cells grow and thrive like flowers. But sometimes, this garden gets old and tired, leading to problems like ulcerative colitis. Researchers Chen J et al. found that NAT10 is like a gardener who's been pruning too hard – it's removing the wrong kinds of growth, making the garden sick. By stopping NAT10 from doing its job, they created an environment where healthy cells could grow back and fix the damage. This breakthrough could lead to new treatments for elderly-onset colitis, helping people feel better and live longer.